The Company’s core business and operational expertise since its inception have been as a service provider in the manufacturing of Generic Drug Substances. Neuland has earned the identity of a preferred and reliable source in the pharmaceutical industry primarily due to:
Neuland has 2 US FDA and EU GMP compliant manufacturing facilities with a collective capacity of 526 KL to produce more than 75 APIs across 10 diverse therapeutic areas.
The Company’s strengths in synthetic chemistry, process development, controlled supply chain and project management approach, built into all our operations and product development programs makes Neuland an ideal API partner for generics.
It has come to our notice that fraudulent recruitment offers are being extended on behalf of Neuland Laboratories Ltd. in the name of Board of Directors by certain individuals/entities.